Grant: Discovery Grants Program - Individual
Concordia University
$39,000.00
Controlling protein machinery: Engineering biosensors, enzymes, and inhibitors
EF 2024-25
Résumé
Proteins act as components of life's molecular machinery. Many important biological processes are co-ordinated with extreme precision by proteins through their interactions with macromolecules like carbohydrates, or with small molecules including primary and secondary metabolites. My research group is pursuing several axes of research to apply control over protein function towards developing new tools for biotechnology.
Firstly, we will develop and apply new strategies to engineer biosensors, which are detection systems consisting of biological components that produce a measurable response to a target molecule. By tailoring specific protein components that switch genes on or off within engineered microbial cells, we will reconfigure them to detect specific molecules, providing us with useful tools to optimize the bioproduction of valuable chemical building blocks. We will also engineer antibody-like proteins to bind to distinctive cell surface carbohydrate molecules-known as glycans-which are made up of a structured pattern of sugar building blocks. Because these glycans act as biomarkers to various states of health and disease, biosensors engineered to detect them can be useful as accurate diagnostics (e.g., to cancer).
Secondly, we will establish new tools and methods to control the enzymes that assemble complex molecules using sugar building blocks. We will accomplish this in one case by engineering the enzymes that add sugar units to assemble therapeutic molecules. Altering the sugar unit that the enzyme attaches will allow us to produce new therapeutics. In another case, we will target the human enzymes that assemble glycan structures on cell surfaces in order to identify molecules that block their activity, which will be useful towards therapeutics to treat diseases like cancer where these enzymes are abnormally overactive.
Thirdly, we will use new methods that we have devised to engineer enzymes that are useful tools for "green chemistry" towards producing flavour molecules, medicines, and polymers. These particular enzymes catalyze the transfer of electrons in key biotransformation steps. We will identify promising enzymes from nature and then engineer improved mutants by directed evolution.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2023-04793
Name nom
Kwan, David
Department département
Biology
Organization id
70
Institution établissement
Concordia University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
39000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5404
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Enzymes
Research subject fr
Enzymes
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Controlling protein machinery: Engineering biosensors, enzymes, and inhibitors
Keywords
synthetic biology; high-throughput biology; chemical biology; protein engineering; directed evolution; biocatalysis; biotransformation; glycobiology; natural products; biorenewables
Application summary
Proteins act as components of life's molecular machinery. Many important biological processes are co-ordinated with extreme precision by proteins through their interactions with macromolecules like carbohydrates, or with small molecules including primary and secondary metabolites. My research group is pursuing several axes of research to apply control over protein function towards developing new tools for biotechnology.
Firstly, we will develop and apply new strategies to engineer biosensors, which are detection systems consisting of biological components that produce a measurable response to a target molecule. By tailoring specific protein components that switch genes on or off within engineered microbial cells, we will reconfigure them to detect specific molecules, providing us with useful tools to optimize the bioproduction of valuable chemical building blocks. We will also engineer antibody-like proteins to bind to distinctive cell surface carbohydrate molecules-known as glycans-which are made up of a structured pattern of sugar building blocks. Because these glycans act as biomarkers to various states of health and disease, biosensors engineered to detect them can be useful as accurate diagnostics (e.g., to cancer).
Secondly, we will establish new tools and methods to control the enzymes that assemble complex molecules using sugar building blocks. We will accomplish this in one case by engineering the enzymes that add sugar units to assemble therapeutic molecules. Altering the sugar unit that the enzyme attaches will allow us to produce new therapeutics. In another case, we will target the human enzymes that assemble glycan structures on cell surfaces in order to identify molecules that block their activity, which will be useful towards therapeutics to treat diseases like cancer where these enzymes are abnormally overactive.
Thirdly, we will use new methods that we have devised to engineer enzymes that are useful tools for "green chemistry" towards producing flavour molecules, medicines, and polymers. These particular enzymes catalyze the transfer of electrons in key biotransformation steps. We will identify promising enzymes from nature and then engineer improved mutants by directed evolution.